Related Experiment Video
Updated: Oct 10, 2025

A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
Published on: February 27, 2018
Dexamethasone and hiccups: a 2000-patient, telephone-based study
Christopher J Ehret1, Jennifer G Le-Rademacher2, Nichole Martin1
1Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Dexamethasone (a steroid) can cause hiccups in about 11% of patients. Many patients found educational materials about managing these hiccups to be very helpful, indicating an unmet need.
Area of Science:
- Pharmacology
- Patient Experience
Background:
- Dexamethasone is a corticosteroid with various therapeutic uses.
- Hiccups are a potential side effect of dexamethasone, often underreported or dismissed.
- The prevalence and patient perception of dexamethasone-induced hiccups are not well-defined.
Purpose of the Study:
- To determine the percentage of patients experiencing hiccups while on dexamethasone.
- To assess patient interest in and perceived helpfulness of educational materials regarding dexamethasone-induced hiccups.
Main Methods:
- A phone survey was conducted with adult outpatients who received dexamethasone within the prior two weeks.
- Participants were asked about experiencing hiccups and offered educational materials.
- Patient opinions on the availability of educational materials were collected using a 5-point Likert scale.
Main Results:
- 11% (127/1186) of surveyed patients reported experiencing hiccups.
- Among those with hiccups, 43% expressed a desire for educational materials.
- Of those who received materials, 43% rated their helpfulness as 'extremely helpful' (5/5).
Conclusions:
- Dexamethasone-induced hiccups affect a notable minority of patients.
- There is a clear patient interest in and positive reception to educational resources for managing these side effects.
- The findings suggest an unmet need for patient education and support concerning dexamethasone-induced hiccups.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Depolarizing Blockers: Pharmocokinetics
Desensitization and Tachyphylaxis